Every recall we track for Amneal Pharmaceuticals of New York, LLC — 26 in all — plus the complaints and injury reports the public filed about them.
Amneal recalls 0.2mg methylergonovine maleate tablets with failed dissolution specs. This may affect medication effectiveness. Check NDC #69238-1605-2 and lot BJ01922A for affected products.
Amneal recalls prescription oseltamivir suspension due to failed impurities tests. This may cause health risks. Check NDC# 69238-1273-6 or lot numbers for affected products.
Amneal Pharmaceuticals recalls 10mg Phenoxybenzamine Hydrochloride capsules due to potential unknown impurities. This prescription drug may pose safety risks. Consumers should contact the manufacturer for details.
Amneal Pharmaceuticals recalls 250mg Divalproex Sodium Extended-release Tablets due to failed dissolution specifications. This may affect medication effectiveness. Check NDC 65162-755-10 and lot numbers AR210704-09 for affected products.
Amneal recalls 100-count Extended Phenytoin Sodium Capsules (100 mg) due to failed dissolution specifications. This may affect medication effectiveness. Check NDC# 65162-212-10 and lot numbers for affected products.
Amneal recalls 100mg phenytoin capsules with failed dissolution specs. This may not release medication properly. Check NDC 65162-212-10 and lot # HL00721A for affected units.
Amneal Pharmaceuticals recalls 1 mL vials of Methylprednisolone Acetate Injectable Suspension due to a typographical error in the NDC number on packaging. Correct NDC is 70121-1574-1; incorrect is 70121-1573-1.
Amneal recalls 4 oz. Flocinolone Acetonide 0.01% Topical Oil due to subpotent drug levels. This may not provide intended treatment. Consumers should contact Amneal for details.
Amneal Pharmaceuticals recalls 4 oz. Flocinolone Acetonide 0.01% Topical Oil due to subpotent drug levels. This may not provide intended treatment. Check NDC 65162-704-86 and lot 07040001A for affected products.